Literature DB >> 24488067

CrossTalk opposing view: the late sodium current is not an important player in the development of diastolic heart failure (heart failure with a preserved ejection fraction).

Zoltán Papp1, Attila Borbély, Walter J Paulus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24488067      PMCID： PMC3930423          DOI： 10.1113/jphysiol.2013.264242

Source DB:  PubMed          Journal:  J Physiol        ISSN： 0022-3751            Impact factor:   5.182


× No keyword cloud information.
  29 in total

Review 1.  CaMKII in myocardial hypertrophy and heart failure.

Authors:  Mark E Anderson; Joan Heller Brown; Donald M Bers
Journal:  J Mol Cell Cardiol       Date:  2011-01-27       Impact factor: 5.000

2.  Phenotypic and pathophysiological heterogeneity in heart failure with preserved ejection fraction.

Authors:  Amil M Shah; Scott D Solomon
Journal:  Eur Heart J       Date:  2012-06-22       Impact factor: 29.983

3.  Ranolazine improves cardiac diastolic dysfunction through modulation of myofilament calcium sensitivity.

Authors:  Joshua D Lovelock; Michelle M Monasky; Euy-Myoung Jeong; Harvey A Lardin; Hong Liu; Bindiya G Patel; Domenico M Taglieri; Lianzhi Gu; Praveen Kumar; Narayan Pokhrel; Dewan Zeng; Luiz Belardinelli; Dan Sorescu; R John Solaro; Samuel C Dudley
Journal:  Circ Res       Date:  2012-02-16       Impact factor: 17.367

4.  ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

Authors:  John J V McMurray; Stamatis Adamopoulos; Stefan D Anker; Angelo Auricchio; Michael Böhm; Kenneth Dickstein; Volkmar Falk; Gerasimos Filippatos; Cândida Fonseca; Miguel Angel Gomez-Sanchez; Tiny Jaarsma; Lars Køber; Gregory Y H Lip; Aldo Pietro Maggioni; Alexander Parkhomenko; Burkert M Pieske; Bogdan A Popescu; Per K Rønnevik; Frans H Rutten; Juerg Schwitter; Petar Seferovic; Janina Stepinska; Pedro T Trindade; Adriaan A Voors; Faiez Zannad; Andreas Zeiher; Jeroen J Bax; Helmut Baumgartner; Claudio Ceconi; Veronica Dean; Christi Deaton; Robert Fagard; Christian Funck-Brentano; David Hasdai; Arno Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Theresa McDonagh; Cyril Moulin; Bogdan A Popescu; Zeljko Reiner; Udo Sechtem; Per Anton Sirnes; Michal Tendera; Adam Torbicki; Alec Vahanian; Stephan Windecker; Theresa McDonagh; Udo Sechtem; Luis Almenar Bonet; Panayiotis Avraamides; Hisham A Ben Lamin; Michele Brignole; Antonio Coca; Peter Cowburn; Henry Dargie; Perry Elliott; Frank Arnold Flachskampf; Guido Francesco Guida; Suzanna Hardman; Bernard Iung; Bela Merkely; Christian Mueller; John N Nanas; Olav Wendelboe Nielsen; Stein Orn; John T Parissis; Piotr Ponikowski
Journal:  Eur J Heart Fail       Date:  2012-08       Impact factor: 15.534

5.  Ranolazine combined with enalapril or metoprolol prevents progressive LV dysfunction and remodeling in dogs with moderate heart failure.

Authors:  Sharad Rastogi; Victor G Sharov; Sudhish Mishra; Ramesh C Gupta; Brent Blackburn; Luiz Belardinelli; William C Stanley; Hani N Sabbah
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-09-26       Impact factor: 4.733

Review 6.  A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.

Authors:  Walter J Paulus; Carsten Tschöpe
Journal:  J Am Coll Cardiol       Date:  2013-05-15       Impact factor: 24.094

Review 7.  Molecular and cellular basis for diastolic dysfunction.

Authors:  Loek van Heerebeek; Constantijn P M Franssen; Nazha Hamdani; Freek W A Verheugt; G Aernout Somsen; Walter J Paulus
Journal:  Curr Heart Fail Rep       Date:  2012-12

8.  Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts--role of late sodium current and intracellular ion accumulation.

Authors:  Samuel Sossalla; Stefan Wagner; Eva C L Rasenack; Hanna Ruff; Sarah L Weber; Friedrich A Schöndube; Theodor Tirilomis; Gero Tenderich; Gerd Hasenfuss; Luiz Belardinelli; Lars S Maier
Journal:  J Mol Cell Cardiol       Date:  2008-03-14       Impact factor: 5.000

9.  RAnoLazIne for the treatment of diastolic heart failure in patients with preserved ejection fraction: the RALI-DHF proof-of-concept study.

Authors:  Lars S Maier; Beth Layug; Ewa Karwatowska-Prokopczuk; Luiz Belardinelli; Stella Lee; Julia Sander; Christian Lang; Rolf Wachter; Frank Edelmann; Gerd Hasenfuss; Claudius Jacobshagen
Journal:  JACC Heart Fail       Date:  2013-04-01       Impact factor: 12.035

10.  Ranolazine inhibits an oxidative stress-induced increase in myocyte sodium and calcium loading during simulated-demand ischemia.

Authors:  Xiu Q Zhang; Shigeyuki Yamada; William H Barry
Journal:  J Cardiovasc Pharmacol       Date:  2008-05       Impact factor: 3.105
View more
  2 in total

1.  Rebuttal from Marc Pourrier, Sarah Williams, Donald McAfee, Luiz Belardinelli and David Fedida.

Authors:  Marc Pourrier; Sarah Williams; Donald McAfee; Luiz Belardinelli; David Fedida
Journal:  J Physiol       Date:  2014-02-01       Impact factor: 5.182

2.  Changes in Intracellular Na+ following Enhancement of Late Na+ Current in Virtual Human Ventricular Myocytes.

Authors:  Karen Cardona; Beatriz Trenor; Wayne R Giles
Journal:  PLoS One       Date:  2016-11-22       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.